http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0252729-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate | 1987-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1990-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0252729-A3 |
| titleOfInvention | Bronchodilatory peptides |
| abstract | The peptides of the formula nX - Tyr - X² - Gly - Phe(4NO₂) - Pro - NH₂ nwherein X is hydrogen or an amidino group and X² is D-S-nmethylmethionyl or D-arginyl, together with their pharmaconlogically acceptable salts, which have been described as exhinbiting analgesic, antidiarrhoeal and antitussive activity, are neffective in reversing neuronally-mediated bronchoconstricntion in mammals. The said compounds have application in nthe palliation of conditions characterised by such a state, in nparticular asthma in human beings. |
| priorityDate | 1986-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.